A dissertation study at the University of Jyväskylä (Finland) developed two-dimensional fishnet-like structures from DNA ...
Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...
TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First ...
No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...
Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...
Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems, has announced the publication of a new study in Nature Biomedical Engineering, titled "Spatial profiling of gene editing by ...
A new review in Chinese Medical Journal details progress in nanocarrier-based cancer therapy. It analyzes polymeric, lipidic, ...
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...
If you have an individual retirement account (IRA), you might have considered converting it into a Roth account at some point. But you might not know the best time to do a conversion, or even if doing ...
Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. The ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback